Literature DB >> 15361889

Genetic variations related to hypertension: a review.

M O M Tanira1, K A Al Balushi.   

Abstract

Hypertension is a complex multifactorial disorder with genetic, environmental and demographic factors contributing to its prevalence. The genetic element contribution to blood pressure variation ranges from 30 to 50%. Therefore, identifying hypertension susceptibility genes will help understanding the pathophysiology of the disease. In addition to the potential impact of genomic information in selecting antihypertensive drug therapy, it may also help in recognizing those at risk of developing the disease, which may lead to new preventive approaches. Several strategies and methods have been used to identify hypertension susceptibility genes. Currently, genetic analysis of such data produced complex results, which makes it difficult to draw final conclusion on the use of genomic data in management of hypertension. This review attempts to summarize present known genetic variations that may be implicated in the pathogenesis of hypertension and to discuss various research strategies used to identify them. It also highlights some of the opportunities and challenges, which may be encountered in interpreting the value of these genetic variations to improve management of hypertension.

Entities:  

Mesh:

Year:  2005        PMID: 15361889     DOI: 10.1038/sj.jhh.1001780

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  32 in total

Review 1.  Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics.

Authors:  Jacob Basson; Jeannette Simino; D C Rao
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

Review 2.  Prehypertension: Underlying pathology and therapeutic options.

Authors:  Sulayma Albarwani; Sultan Al-Siyabi; Musbah O Tanira
Journal:  World J Cardiol       Date:  2014-08-26

3.  Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in northern Han Chinese population.

Authors:  Qi Zhao; Zhongjie Fan; Jiang He; Shufeng Chen; Hongfan Li; Penghua Zhang; Laiyuan Wang; Dongsheng Hu; Jianfeng Huang; Boqin Qiang; Dongfeng Gu
Journal:  J Mol Med (Berl)       Date:  2007-01-10       Impact factor: 4.599

4.  Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke.

Authors:  Martin Horan; Vicky Newsway; Mark D Lewis; Tammy E Easter; D Aled Rees; Arti Mahto; David S Millar; Annie M Procter; Maurice F Scanlon; Ian B Wilkinson; Ian P Hall; Amanda Wheatley; John Blakey; Philip M W Bath; John R Cockcroft; Michael Krawczak; David N Cooper
Journal:  Hum Genet       Date:  2006-03-30       Impact factor: 4.132

5.  Prevalence of H1299R polymorphism in the Factor V gene among the Taif-Saudi Arabia population using polymerase chain reaction-reverse hybridization technique.

Authors:  Nabil Saied Awad; Adel El-Sayed El-Tarras
Journal:  Mol Biol Rep       Date:  2011-05-07       Impact factor: 2.316

Review 6.  Application of serial analysis of gene expression to the study of human genetic disease.

Authors:  Martin P Horan
Journal:  Hum Genet       Date:  2009-07-10       Impact factor: 4.132

7.  Hypertension genes and retinal vascular calibre: the Cardiovascular Health Study.

Authors:  C Sun; J J Wang; F M Islam; S R Heckbert; R Klein; D S Siscovick; B E K Klein; T Y Wong
Journal:  J Hum Hypertens       Date:  2009-01-15       Impact factor: 3.012

Review 8.  CYP3A5 polymorphism, amlodipine and hypertension.

Authors:  Y-P Zhang; X-C Zuo; Z-J Huang; J-J Cai; J Wen; D D Duan; H Yuan
Journal:  J Hum Hypertens       Date:  2013-07-18       Impact factor: 3.012

9.  The association study on renalase polymorphism and hypertension: a meta-analysis.

Authors:  Wei-Bin Shi; Hong-Yong Wang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 10.  Neuroimmune crosstalk in the pathophysiology of hypertension.

Authors:  Laura Calvillo; Mariela M Gironacci; Lia Crotti; Pier Luigi Meroni; Gianfranco Parati
Journal:  Nat Rev Cardiol       Date:  2019-08       Impact factor: 32.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.